 |
|
Management of refractory ascites
Florence Wong
Clin Mol Hepatol. 2023;29(1):16-32. Published online 2022 Jun 9 DOI: https://doi.org/10.3350/cmh.2022.0104
|
|
Citations to this article as recorded by
 Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa
Mark W Sonderup, Patrick S Kamath, Yaw A Awuku, Hailemichael Desalegn, Neliswa Gogela, Leolin Katsidzira, Christian Tzeuton, Bilal Bobat, Chris Kassianides, C Wendy Spearman
The Lancet Gastroenterology & Hepatology.2024; 9(2): 170. CrossRef Recent developments in the management of ascites in cirrhosis
Tian Lan, Ming Chen, Chengwei Tang, Pierre Deltenre
United European Gastroenterology Journal.2024; 12(2): 261. CrossRef A new strategy for the treatment of refractory ascites in patients with hepatitis B-related liver cirrhosis
Wenjing Xu, Gang Wang
Asian Journal of Surgery.2024;[Epub] CrossRef Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis
Shingo Koyama, Asako Nogami, Masato Yoneda, Shihyao Cheng, Yuya Koike, Yuka Takeuchi, Michihiro Iwaki, Takashi Kobayashi, Satoru Saito, Daisuke Utsunomiya, Atsushi Nakajima
Tomography.2024; 10(4): 471. CrossRef Review article: Recent advances in ascites and acute kidney injury management in cirrhosis
Danielle Adebayo, Florence Wong
Alimentary Pharmacology & Therapeutics.2024; 59(10): 1196. CrossRef Daily Low-Volume Paracentesis and Clinical Complications in Patients With Refractory Ascites
Tammo L. Tergast, Marie Griemsmann, Lena Stockhoff, Kerstin Port, Benjamin Heidrich, Markus Cornberg, Heiner Wedemeyer, Henrike Lenzen, Nicolas Richter, Elmar Jaeckel, Benjamin Maasoumy
JAMA Network Open.2023; 6(7): e2322048. CrossRef Effect of different infusion approaches on safety and efficacy of terlipressin: Current controversies
Yong He, Lu Chai, Han Chen, Xing-Shun Qi
World Chinese Journal of Digestology.2023; 31(17): 705. CrossRef Evidence-based hyponatremia management in liver disease
Ji Young Ryu, Seon Ha Baek, Sejoong Kim
Clinical and Molecular Hepatology.2023; 29(4): 924. CrossRef Prevalence and risk factors of lymphatic dysfunction in cirrhosis patients with refractory ascites: An often unconsidered mechanism
Rahul Arya, Ramesh Kumar, Tarun Kumar, Sudhir Kumar, Utpal Anand, Rajeev Nayan Priyadarshi, Tanmoy Maji
World Journal of Hepatology.2023; 15(10): 1140. CrossRef Pulmonary Complications in Patients with Liver Cirrhosis
Seul Ki Han, Soon Koo Baik, Moon Young Kim
The Korean Journal of Gastroenterology.2023; 82(5): 213. CrossRef Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy—A Review of the Past Decade’s Literature Focusing on Incidence, Risk Factors, and Prophylaxis
Karina Holm Friis, Karen Louise Thomsen, Wim Laleman, Sara Montagnese, Hendrik Vilstrup, Mette Munk Lauridsen
Journal of Clinical Medicine.2023; 13(1): 14. CrossRef
|